Table 2.
Vehicle | Solulin | |||
---|---|---|---|---|
Gene | Contralateral [%] | Ipsilateral [%] | Contralateral [%] | Ipsilateral [%] |
IL-1β | 100 | 1165.5 ± 1522.1 | 46.6 ± 42.8 | 242.7 ± 443.4 |
IL-6 | 100 | 775.2 ± 724.4 | 26.1 ± 22.2 | 411.7 ± 550.6 |
TNF-α | 100 | 206.2 ± 278.9 | 86.1 ± 92.4 | 83.9 ± 56.9 |
MMP-9 | 100 | 257.6 ± 131.1 | 41.9 ± 46.5 | 201.6 ± 97.1 |
CD11B | 100 | 236.2 ± 56.1 | 86.6 ± 85.5 | 119.6 ± 102.8 |
GFAP | 100 | 108.4 ± 69.5 | 71.7 ± 89.7 | 87.1 ± 89.7 |
Gene expression of three consecutive coronal sections of TTC-stained hemispheres. The contralateral non-infarcted hemispheres of the vehicle-treated group acted as internal controls. Values of these hemispheres were therefore set to 100%. All other values (infarcted hemisphere vehicle-treated group, infarcted and non-infarcted hemisphere of the Solulin cohort) were expressed as percentages of the latter. RT-PCR values were normalized to the housekeeping gene HPRT and cyclophilin A. All mRNA levels are given as means ± SD.